Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...
The Novo Nordisk Patient Assistance Program (PAP) is based on the company’s commitment to people living with diabetes. The PAP provides medication at no cost to those who qualify. Patients who are ...
A technical flaw has resulted in “unauthorized access” to personal information at Johnson & Johnson’s Janssen CarePath patient assistance program, IBM reported on Wednesday. After an internal ...
In the search to lower out-of-pocket costs for prescription drugs, consumers will encounter a number of different coupons, discounts and assistance programs available to them. They don't all work the ...
RxBenefits is debuting two new Patient Assistance solutions. Designed to complement RxBenefits' comprehensive suite of pharmacy solutions, these alternative funding offerings can help reduce specialty ...
Dexcom to Launch Patient Assistance Program for Current U.S. Customers Impacted by COVID-19 Pandemic
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) systems for people with diabetes, announced today a new patient assistance program to aid ...
The Lupus Foundation of America knows that it is difficult to live with lupus. The cost of living with this cruel disease can put a strain on your financial resources. Below we have put together a ...
Healthcare compliance risks exist even when a company takes steps to structure its business activities to follow the government's own statements. A recent decision by the U.S. District Court for the ...
Nearly all of major AIDS drug companies have some form of patient assistance program to provide medications to patients in need who for whatever reason—lack of insurance coverage, lack of money to ...
AbbVie is facing a lawsuit from a pharmaceutical assistance company stemming from the drugmaker discouraging patients and employers from doing business with the company and naming it in a lawsuit in ...
Trump Administration Finalizes Rulemaking on Value-Based Purchasing, Multiple Best Prices, Expanded Alternative URA, and other MDRP Drug Pricing Changes On December 21, 2020, the Centers for Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback